» Articles » PMID: 10209277

Comparison of Physical Chemical Properties of Llama VHH Antibody Fragments and Mouse Monoclonal Antibodies

Overview
Specialties Biochemistry
Biophysics
Date 1999 Apr 21
PMID 10209277
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Antigen specific llama VHH antibody fragments were compared to antigen specific mouse monoclonal antibodies with respect to specificity, affinity and stability. The llama VHH antibody fragments and the mouse monoclonal antibodies investigated were shown to be highly specific for the protein antigen hCG or the hapten antigen RR-6. The affinity of the interaction between monovalent llama VHH antibody fragments and their antigen is close to the nanomolar range, similar to the bivalent mouse monoclonal antibodies studied. Llama VHH antibody fragments are similar to mouse monoclonal antibodies with respect to antigen binding in the presence of ammonium thiocyanate and ethanol. The results show that relative to antigen specific mouse monoclonal antibodies, antigen specific llama VHH fragments are extremely temperature stable. Two out of six llama VHHs are able to bind antigen specifically at temperatures as high as 90 degrees C, whereas four out of four mouse monoclonal antibodies are not functional at this temperature. Together with the finding that llama VHH fragments can be produced at high yield in Saccharomyces cerevisiae, these findings indicate that in the near future antigen specific llama VHH fragments can be used in for antibodies unexpected products and processes.

Citing Articles

Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo.

Zhang Y, Tian C, Yu X, Yu G, Han X, Wang Y Vaccines (Basel). 2025; 12(12.

PMID: 39771977 PMC: 11680347. DOI: 10.3390/vaccines12121315.


Enhancing Anti-Cancer Immune Response by Acidosis-Sensitive Nanobody Display.

Knepper L, Ankrom E, Thevenin D J Membr Biol. 2024; 257(5-6):391-401.

PMID: 39254684 PMC: 11584308. DOI: 10.1007/s00232-024-00322-3.


Developability considerations for bispecific and multispecific antibodies.

Amash A, Volkers G, Farber P, Griffin D, Davison K, Goodman A MAbs. 2024; 16(1):2394229.

PMID: 39189686 PMC: 11352713. DOI: 10.1080/19420862.2024.2394229.


Advancements in Chemical and Biosensors for Point-of-Care Detection of Acrylamide.

Xie M, Lv X, Wang K, Zhou Y, Lin X Sensors (Basel). 2024; 24(11).

PMID: 38894291 PMC: 11175246. DOI: 10.3390/s24113501.


Nanobody-based CAR NK cells for possible immunotherapy of MICA tumors.

Verhaar E, van Keizerswaard W, Knoflook A, Balligand T, Ploegh H PNAS Nexus. 2024; 3(5):pgae184.

PMID: 38756234 PMC: 11096969. DOI: 10.1093/pnasnexus/pgae184.